Acute severe presentations of autoimmune hepatitis (AIH) represent a challenge for the
transplant community. As a disease, it is poorly characterized, and there is a weak evidence …

Background & Aims In acute severe autoimmune hepatitis (AS-AIH), the optimal timing for
liver transplantation (LT) remains controversial. The objectives of this study were to …

Background & Aims No standardised definition exists for acute, severe AIH (AS-AIH).
However, rapid identification of AS-AIH and early corticosteroid therapy may prevent the …

Acute and fulminant forms of autoimmune hepatitis were recognized by the International
Autoimmune Hepatitis Group in 1992 when it codified diagnostic criteria and waived the …

Aims The definition of original acute severe autoimmune hepatitis (AS‐AIH) is unclear.
However, its rapid recognition and early treatment is potentially life‐saving. Therefore, we …

Autoimmune hepatitis (AIH) is a disease of unknown etiology, its hallmark being ongoing
hepatic inflammation. By its very nature, it is a chronic condition, although increasingly, we …

Immunosuppressive therapy, and particularly corticosteroids with or without azathioprine,
can achieve a remission in more than 80% of patients with autoimmune hepatitis (AIH). By …

There is a paucity of information related to the usefulness of corticosteroid therapy in
autoimmune hepatitis (AIH) with decompensated cirrhosis. In this study, we sought to …

Autoimmune hepatitis (AIH) is a complex autoimmune disease characterized by immune-
mediated destruction of hepatic parenchyma which can result in cirrhosis, liver failure, and …

Presentation of autoimmune hepatitis (AIH) can differ from nonacute to acute autoimmune
hepatitis (A‐AIH) with jaundice and acute severe autoimmune hepatitis (AS‐AIH) with …